The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Nanoparticles and the Brain: Cause for Concern?
Open accessAbstract
Engineered nanoparticles (NPs) are in the same size category as atmospheric ultrafine particles, < 100 nm. Per given volume, both have high numbers and surface areas compared to larger particles. The high proportion of surface atoms/molecules can give rise to a greater chemical as well as biological activity, for example the induction of reactive oxygen species in cell-free medium as well as in cells. When inhaled as singlet particles, NPs of different sizes deposit efficiently in all regions of the respiratory tract by diffusion. A major difference to larger size particles is the propensity of NPs to translocate across cell barriers from the portal of entry (e.g., the respiratory tract) to secondary organs and to enter cells by various mechanisms and associate with subcellular structures. This makes NPs uniquely suitable for therapeutic and diagnostic uses, but it also leaves target organs such as the central nervous system (CNS) vulnerable to potential adverse effects (e.g., oxidative stress). Neuronal transport of NPs has been described, involving retrograde and anterograde movement in axons and dendrites as well as perineural translocation. This is of importance for access of inhaled NPs to the CNS via sensory nerves existing in the nasopharyngeal and tracheobronchial regions of the respiratory tract. The neuronal pathway circumvents the very tight blood brain barrier. In general, translocation rates of NP from the portal of entry into the blood compartment or the CNS are very low. Important modifiers of translocation are the physicochemical characteristics of NPs, most notably their size and surface properties, particularly surface chemistry. Primary surface coating (when NPs are manufactured) and secondary surface coating (adsorption of lipids/proteins occurring at the portal of entry and during subsequent translocation) can significantly alter NP biokinetics and their effects. Implications of species differences in respiratory tract anatomy, breathing pattern and brain anatomy for extrapolation to humans of NP effects observed in rodents need to be considered. Although there are anecdotal data indicating a causal relationship between long-term ultrafine particle exposures in ambient air (e.g., traffic related) or at the workplace (e.g., metal fumes) and resultant neurotoxic effects in humans, more studies are needed to test the hypothesis that inhaled nanoparticles cause neurodegenerative effects. Some but probably not the majority of NPs will have a significant toxicity (hazard) potential, and this will pose a significant risk if there is a sufficient exposure. The challenge is to identify such hazardous NPs and take appropriate measures to prevent exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Self-citationRenal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476 · cited 1×
“NPs translocating into the blood circulation can be eliminated via the kidneys; this elimination route seems to be limited by size to about 5 nm (Choi et al., 2007).”
BackgroundCedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Translocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Self-citationTranslocation of Inhaled Ultrafine Manganese Oxide Particles to the CentralNervous System
Elder, A., Gelein, R., Silva, V., Feikert, T., Opanashuk, L., Carter, J., Potter, R., Maynard, A., Ito, Y., Finkelstein, J., et al. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9030 · Cited by 1,180
Self-citationSingh, R., Pantarotto, D., Lacerda, L., Pastorin, G., Klumpp, C., Prato, M., Bianco, A., & Kostarelos, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509009103 · Cited by 1,043
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907 · cited 2×
“198Au activity in CSF can be interpreted as input from perineural transport of nanogold particles which has been described as a very rapid translocation route from nose to brain (Illum, 2000).”
BackgroundNucleation of protein fibrillation by nanoparticles
Linse, S., Cabaleiro-Lago, C., Xue, W.-F., Lynch, I., Lindman, S., Thulin, E., Radford, S. E., & Dawson, K. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701250104 · Cited by 886
Long, T. C., Saleh, N., Tilton, R. D., Lowry, G. V., & Veronesi, B. (2006) · Environmental Science & Technology · doi:10.1021/es060589n · Cited by 870
Kreyling, W. G., Semmler, M., Erbe, F., Mayer, P., Takenaka, S., Schulz, H., Oberdörster, G., & Ziesenis, A. (2002) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/00984100290071649 · Cited by 790
Self-citation
Cited by
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Environmental behavior and ecotoxicity of engineered nanoparticles to algae, plants, and fungi
Navarro, E., Baun, A., Behra, R., Hartmann, N. B., Filser, J., Miao, A.-J., Quigg, A., Santschi, P. H., & Sigg, L. (2008) · Ecotoxicology · doi:10.1007/s10646-008-0214-0 · Cited by 1,772
Elsaesser, A., & Howard, C. V. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.001 · Cited by 895
Green Synthesis of Metallic Nanoparticles: Applications and Limitations
Dikshit, P., Kumar, J., Das, A., Sadhu, S., Sharma, S., Singh, S., Gupta, P., & Kim, B. (2021) · Catalysts · doi:10.3390/catal11080902 · Cited by 882
The Adverse Effects of Air Pollution on the Nervous System
Genc, S., Zadeoglulari, Z., Fuss, S. H., & Genc, K. (2012) · Journal of Toxicology · doi:10.1155/2012/782462 · Cited by 717
Toxicology and clinical potential of nanoparticles
Yildirimer, L., Thanh, N. T. K., Loizidou, M., & Seifalian, A. M. (2011) · Nano Today · doi:10.1016/j.nantod.2011.10.001 · Cited by 676
Traffic-Related Air Pollution, Particulate Matter, and Autism
Volk, H. E., Lurmann, F., Penfold, B., Hertz-Picciotto, I., & McConnell, R. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.266 · Cited by 638
“These particles translocate indirectly through the lungs and from the systemic circulation or directly via the nasal mucosa and the olfactory bulb into the brain.(39,40) Toxicity may be mediated by the physical properties of PM or by the diverse mixture of organic compounds, including polycyclic aromatic hydrocarbons,…”
Nanotoxicology: An Interdisciplinary Challenge
Krug, H. F., & Wick, P. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201001037 · Cited by 556
The outdoor air pollution and brain health workshop
Block, M. L., Elder, A., Auten, R. L., Bilbo, S. D., Chen, H., Chen, J.-C., Cory-Slechta, D. A., Costa, D., Diaz-Sanchez, D., Dorman, D. C., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.08.014 · Cited by 539
Self-citationAranda, A., Sequedo, L., Tolosa, L., Quintas, G., Burello, E., Castell, J. V., & Gombau, L. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.01.016 · Cited by 487
Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
EFSA Scientific Committee, Hardy, A., Benford, D., Halldorsson, T., Jeger, M. J., Knutsen, H. K., More, S., Naegeli, H., Noteborn, H., Ockleford, C., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5327 · Cited by 416
Berg, J. M., Romoser, A., Banerjee, N., Zebda, R., & Sayes, C. M. (2009) · Nanotoxicology · doi:10.3109/17435390903276941 · Cited by 364
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357
Neurodegenerative and neurological disorders by small inhaled particles
Heusinkveld, H. J., Wahle, T., Campbell, A., Westerink, R. H. S., Tran, L., Johnston, H., Stone, V., Cassee, F. R., & Schins, R. P. F. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.07.007 · Cited by 331
Neurotoxic effect of active ingredients in sunscreen products, a contemporary review
Ruszkiewicz, J. A., Pinkas, A., Ferrer, B., Peres, T. V., Tsatsakis, A., & Aschner, M. (2017) · Toxicology Reports · doi:10.1016/j.toxrep.2017.05.006 · Cited by 323
Paur, H.-R., Cassee, F. R., Teeguarden, J., Fissan, H., Diabate, S., Aufderheide, M., Kreyling, W. G., Hänninen, O., Kasper, G., Riediker, M., et al. (2011) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2011.06.005 · Cited by 316
Synthesis, biomedical applications, and toxicity of CuO nanoparticles
Naz, S., Gul, A., Zia, M., & Javed, R. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12364-z · Cited by 279
Haase, A., Rott, S., Mantion, A., Graf, P., Plendl, J., Thünemann, A. F., Meier, W. P., Taubert, A., Luch, A., & Reiser, G. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs003 · Cited by 252
Allen, J. L., Oberdorster, G., Morris-Schaffer, K., Wong, C., Klocke, C., Sobolewski, M., Conrad, K., Mayer-Proschel, M., & Cory-Slechta, D. A. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2015.12.014 · Cited by 241
“…that air pollutionassociated CNS pathology reflects interactive pathways that include systemic inflammation, as mediated e.g., by vagal nerve afferents (Oberdorster et al., 2004, 2009), in conjunction with direct effects of particulate matter on brain tissue (Block and Calderon-Garciduenas., 2009).”
Chambliss, S. E., Pinon, C. P. R., Messier, K. P., LaFranchi, B., Upperman, C. R., Lunden, M. M., Robinson, A. L., Marshall, J. D., & Apte, J. S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109249118 · Cited by 156
In vivo effects: Methodologies and biokinetics of inhaled nanomaterials
Oberdörster, G., & Kuhlbusch, T. A. J. (2018) · NanoImpact · doi:10.1016/j.impact.2017.10.007 · Cited by 88
Self-citationKlocke, C., Allen, J. L., Sobolewski, M., Mayer-Pröschel, M., Blum, J. L., Lauterstein, D., Zelikoff, J. T., & Cory-Slechta, D. A. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx010 · Cited by 87
Macromolecular Coronas and Their Importance in Nanotoxicology and Nanoecotoxicology
Lynch, I., Dawson, K. A., Lead, J. R., & Valsami-Jones, E. (2014) · Frontiers of Nanoscience · doi:10.1016/b978-0-08-099408-6.00004-9 · Cited by 61
Lalancette-Hébert, M., Moquin, A., Choi, A. O., Kriz, J., & Maysinger, D. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1000372 · Cited by 39
Psychological Impacts of Climate Change and Recommendations
Van Susteren, L., & Al-Delaimy, W. K. (2020) · Health of People, Health of Planet and Our Responsibility · doi:10.1007/978-3-030-31125-4_14 · Cited by 25
Metadata
- Authors
- Oberdörster, G., Elder, A., & Rinderknecht, A.
- Venue
- Journal of Nanoscience and Nanotechnology
- Publisher
- American Scientific Publishers
- Published
- 2009-08-01
- Volume
- 9
- Issue
- 8
- Pages
- 4996-5007
- ISSN
- 1533-4880 (ISSN-L)
- OpenAlex
- W2000893894
- Cited by
- 371
- References
- 35
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.